The Clorox Company
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +665.0% | +19.0% | +86.8% | -35.0% | -18.6% | +58.9% | +2.8% | -68.4% | +234.4% | -139.2% | – | – | |
| – | -6.6% | +1.8% | +1.7% | -8.5% | -1.9% | +3.8% | +3.6% | -1.8% | -1.8% | +5.5% | +34.5% | – | |
| – | +23.1% | +62.5% | -26.9% | -31.6% | +107.7% | -11.1% | -29.2% | -41.2% | +140.0% | +62.5% | -102.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -885.7% | – | – | -459.3% | – | – | -123.9% | – | – | |
| – | +116.7% | +5.8% | +47.3% | -51.9% | +35.9% | +0.0% | +41.5% | -52.0% | +16.7% | +2.4% | +100.0% | – | |
| – | +43.5% | +15.2% | +113.2% | – | -160.7% | -1.9% | +43.4% | -55.3% | +26.5% | +0.0% | +4,972.1% | – | |
| – | +0.0% | -0.7% | +0.7% | +1.3% | +0.0% | -0.7% | +0.0% | +0.7% | +0.0% | -0.7% | +0.0% | – | |
| – | +1,733.3% | -100.0% | – | – | +40.2% | – | -129.2% | +72.0% | -1.6% | – | -100.0% | – | |
| – | – | – | – | – | – | -172.8% | -62.7% | – | -58.4% | +1,336.0% | -23.0% | – | |
| – | -267.1% | +7.3% | -1.8% | -13.2% | -54.0% | +174.3% | -6.7% | -78.9% | +255.9% | – | -28.0% | – | |
| – | -206.6% | – | – | – | -84.0% | -641.7% | – | – | – | +1,496.7% | -209.0% | – | |
| – | – | +25.7% | +103.9% | -29.7% | -30.2% | +83.5% | -6.0% | -74.0% | +371.9% | -161.3% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.